Emory International Law Review


This Comment argues that if a group of people, or the international community as a whole, should at any point wish to prevent the ownership of morally controversial biotechnology, then the international community should take steps towards international uniformity. Uniformity in these decisions would arguably need to include uniformity on subject matter eligibility decisions across countries.